tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MaxCyte Weighs Delisting from AIM to Prioritize Nasdaq: Potential Benefits and Risks Ahead
Company AnnouncementsMaxCyte Weighs Delisting from AIM to Prioritize Nasdaq: Potential Benefits and Risks Ahead
14h ago
MXCT
MaxCyte’s Revenue Grows and Strategic Moves Unveiled
PremiumCompany Announcements
MaxCyte’s Revenue Grows and Strategic Moves Unveiled
2d ago
MXCT
MaxCyte Files Quarterly Report, Highlights Financial Progress
PremiumCompany Announcements
MaxCyte Files Quarterly Report, Highlights Financial Progress
2d ago
MXCT
MaxCyte reports Q3 EPS (11c), consensus (12c)
PremiumThe Fly
MaxCyte reports Q3 EPS (11c), consensus (12c)
2d ago
MXCT
MaxCyte Director Sells Shares Amid Active Trading
PremiumCompany Announcements
MaxCyte Director Sells Shares Amid Active Trading
2d ago
MXCT
MaxCyte Expands Stock Capital with New Issuance
PremiumCompany AnnouncementsMaxCyte Expands Stock Capital with New Issuance
4d ago
MXCT
MaxCyte to Join Key Investor Conferences in November
Premium
Company Announcements
MaxCyte to Join Key Investor Conferences in November
8d ago
MXCT
MaxCyte’s Insider Stock Activity in Focus
Premium
Company Announcements
MaxCyte’s Insider Stock Activity in Focus
9d ago
MXCT
MaxCyte Awards Stock Options to Boost Growth
PremiumCompany Announcements
MaxCyte Awards Stock Options to Boost Growth
21d ago
MXCT
MaxCyte appoints Cynthia Collins to board of directors
PremiumThe Fly
MaxCyte appoints Cynthia Collins to board of directors
24d ago
EDIT
MXCT
MaxCyte Strengthens Board with Cynthia Collins Appointment
PremiumCompany Announcements
MaxCyte Strengthens Board with Cynthia Collins Appointment
24d ago
MXCT
MaxCyte to Unveil Q3 2024 Financial Results
PremiumCompany Announcements
MaxCyte to Unveil Q3 2024 Financial Results
28d ago
MXCT
MaxCyte Names New CCO for Market Expansion
PremiumCompany AnnouncementsMaxCyte Names New CCO for Market Expansion
29d ago
MXCT
MaxCyte appoints Soleymannezhad as CCO
Premium
The Fly
MaxCyte appoints Soleymannezhad as CCO
29d ago
MXCT
MaxCyte upgraded to Buy from Hold at Deutsche Bank
Premium
The Fly
MaxCyte upgraded to Buy from Hold at Deutsche Bank
29d ago
MXCT
MaxCyte Director Executes Stock Options Sale
PremiumCompany Announcements
MaxCyte Director Executes Stock Options Sale
1M ago
MXCT
MaxCyte Director Executes Stock Options and Sells Shares
PremiumCompany Announcements
MaxCyte Director Executes Stock Options and Sells Shares
1M ago
MXCT
MaxCyte Expands Share Capital, Fuels Cell Therapy Growth
PremiumCompany Announcements
MaxCyte Expands Share Capital, Fuels Cell Therapy Growth
1M ago
MXCT
BlackRock Adjusts Stake in MaxCyte, Inc.
PremiumCompany Announcements
BlackRock Adjusts Stake in MaxCyte, Inc.
1M ago
MXCT
BlackRock Increases Stake in MaxCyte, Inc.
PremiumCompany AnnouncementsBlackRock Increases Stake in MaxCyte, Inc.
1M ago
MXCT
BlackRock Ups Stake in MaxCyte to 9.75%
Premium
Company Announcements
BlackRock Ups Stake in MaxCyte to 9.75%
2M ago
MXCT
MaxCyte, Kamau Therapeutics enter strategic platform license agreement
Premium
The Fly
MaxCyte, Kamau Therapeutics enter strategic platform license agreement
2M ago
MXCT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >